| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 716,573 | 685,184 | 660,012 | 755,282 | | Cost of Revenue | 492,180 | 471,034 | 453,633 | 514,876 | | | Gross Profit | 224,393 | 214,150 | 206,379 | 240,406 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 100,103 | 98,672 | 95,694 | 98,006 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 124,290 | 115,478 | 110,685 | 142,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (345) | (382) | (215) | (2,674) | | Earnings Before Interest And Taxes | 123,945 | 115,096 | 110,470 | 139,726 | | Interest Expense | 8,961 | 9,131 | 8,998 | 10,041 | | Income Before Tax | 114,984 | 105,965 | 101,472 | 129,685 | | Income Tax Expense | 31,620 | 29,140 | 24,422 | 30,952 | | Minority Interest | 4,595 | (4,595) |
-
|
-
| | | | Net Income From Continuing Ops | 87,959 | 72,230 | 77,050 | 98,733 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 87,959 | 72,230 | 77,050 | 98,733 | | Preferred Stock And Other Adjustments | (7,044) | 2,640 | (2,640) |
-
| | | Net Income Applicable To Common Shares | $80,915 | $74,870 | $74,410 | $98,733 |
|
0.51% Nasdaq 
Income Statement
